Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05298709 · ClinicalTrials.gov registry record · NA
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05298709 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 5 participants.
The verdict
NCT05298709, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal is to characterize vascular reactivity and cardiac pulsatility of normal appearing white matter in patients with CCM during hypercarbia/hypocarbia using quantitative real-time high-speed multi-echo fMRI to develop prognostic biomarkers for CCM formation
Interventions
- OTHER Hyperventilation and CO2 challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2024-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05298709
The ClinicalTrials.gov registry entry for NCT05298709 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperventilation and CO2 challenge is the first listed.
NCT05298709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05298709 about?
NCT05298709 is a clinical study titled "Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)". The goal is to characterize vascular reactivity and cardiac pulsatility of normal appearing white matter in patients with CCM during hypercarbia/hypocarbia using quantitative real-time high-speed multi-echo fMRI to develop prognostic biomarkers for CCM formation
What is the current status of trial NCT05298709?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2023-06-15. Estimated completion is 2024-07-17.
What interventions are being tested in trial NCT05298709?
The interventions under investigation include: Hyperventilation and CO2 challenge (OTHER).
Who is sponsoring clinical trial NCT05298709?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.